Leuprorelin Sandoz Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Leuprorelin

Indications/Uses

Palliative treatment of patients w/ advanced hormone-dependent prostate carcinoma.

Dosage/Direction for Use

SC Single dose of 3.6 mg once mthly or 5 mg once every 3 mth.

Contraindications

Hypersensitivity to leuprorelin or to other GnRH analogues. Confirmed hormone independence of carcinoma. Women. Childn.

MIMS Class

Other Drugs Affecting Hormonal Regulation

ATC Classification

L02AE02 - leuprorelin ; Belongs to the class of gonadotropin releasing hormone analogues. Used in endocrine therapy.

Regulatory Classification

POM

Presentation/Packing

Form

Leuprorelin Sandoz implant 3.6 mg

Packing/Price

1's

Form

Leuprorelin Sandoz implant 5 mg

Packing/Price

1's

Leuprorelin Sandoz

leuprorelin

Manufacturer:

EVER Pharma